Physician profile
Salim Daouk
NPI 1740544006
$822.77
in general payments reported to CMS, 2019-2025
16 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $96.19 · 2023: $15.27 · 2024: $11.68 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $153.23 | 2019-2025 | Nucala |
| Mallinckrodt Enterprises LLC | $89.81 | 2019 | |
| Baxter Healthcare | $51.71 | 2025 | Hillrom - Monarch Airway Clearance System |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.77 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $35.57 | 2019-2020 | |
| Insmed, INC. | $33.15 | 2019-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $28.26 | 2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $27.76 | 2019 | |
| Inogen, INC. | $26.95 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| La Jolla Pharmaceutical Company | $20.43 | 2020 | |
| United Therapeutics Corporation | $19.67 | 2019 | |
| Edwards Lifesciences Corporation | $18.22 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salim Daouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.